Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT) by Julia-Tatjana Maul, Melike Ak, Sara E. Cerminara, Simona Steinmann, Elisabeth V. Goessinger, Anna Darzina, Iker Oyanguren Monferrer, Raphael Micheroli, Georgios Kokolakis, Elisabeth Roider, Felix Oestereich, Eva Mateu, Martina Burlando, Alexander A. Navarini, Thomas Kündig, Lara Valeska Maul

Connect to this object online.